Other Viruses Citation List: November 22 - December 5, 2013
Hepatitis B Virus
1. Cyclosporin A Inhibits Hepatitis B and Hepatitis D Virus Entry by Cyclophilin-independent Interference with the NTCP Receptor. Nkongolo, S., Y. Ni, F.A. Lempp, C. Kaufman, T. Lindner, K. Esser-Nobis, V. Lohmann, W. Mier, S. Mehrle, and S. Urban. Journal of Hepatology, 2013. [Epub ahead of print]; PMID[24295872].
[PubMed]. OV_1122-120513.
2. Antiviral Activity of Bifidobacterium adolescentis SPM0212 against Hepatitis B Virus. Lee do, K., J.Y. Kang, H.S. Shin, I.H. Park, and N.J. Ha. Archives of Pharmacal Research, 2013. 36(12): p. 1525-1532; PMID[23657805].
[PubMed]. OV_1122-120513.
3. Astataricusones A-D and Astataricusol A, Five New Anti-HBV Shionane-Type Triterpenes from Aster tataricus L. f. Zhou, W.B., G.Z. Zeng, H.M. Xu, W.J. He, and N.H. Tan. Molecules, 2013. 18(12): p. 14585-14596; PMID[24287992].
[PubMed]. OV_1122-120513.
Hepatitis C Virus
4. Adapted J6/JFH1-Based Hepatitis C Virus Recombinants with Genotype-specific NS4A Show Similar Efficacies against Lead Protease Inhibitors, Alpha Interferon, and a Putative NS4A Inhibitor. Gottwein, J.M., S.B. Jensen, S.B. Serre, L. Ghanem, T.K. Scheel, T.B. Jensen, H. Krarup, N. Uzcategui, L.S. Mikkelsen, and J. Bukh. Antimicrobial Agents and Chemotherapy, 2013. 57(12): p. 6034-6049; PMID[24060868].
[PubMed]. OV_1122-120513.
5. Differential Effect of P7 Inhibitors on Hepatitis C Virus Cell-to-Cell Transmission. Meredith, L.W., N. Zitzmann, and J.A. McKeating. Antiviral Research, 2013. 100(3): p. 636-639; PMID[24157306].
[PubMed]. OV_1122-120513.
6. Humanized-VH/VHH that Inhibit HCV Replication by Interfering with the Virus Helicase Activity. Phalaphol, A., K. Thueng-In, J. Thanongsaksrikul, O. Poungpair, K. Bangphoomi, N. Sookrung, P. Srimanote, and W. Chaicumpa. Journal of Virological Methods, 2013. 194(1-2): p. 289-299; PMID[24036073].
[PubMed]. OV_1122-120513.
7. Sofosbuvir (GS-7977), a Pan-genotype, Direct-Acting Antiviral for Hepatitis C Virus Infection. Rodriguez-Torres, M. Expert Review of Anti-Infective Therapy, 2013. 11(12): p. 1269-1279; PMID[24215243].
[PubMed]. OV_1122-120513.
8. Structure-Activity Relationship (SAR) Optimization of 6-(Indol-2-yl)pyridine-3-sulfonamides: Identification of Potent, Selective and Orally Bioavailable Small Molecules Targeting Hepatitis C (HCV) NS4B. Zhang, N., X. Zhang, J. Zhu, A. Turpoff, G. Chen, C. Morrill, S. Huang, W. Lennox, R. Kakarla, R. Liu, C. Li, H. Ren, N.G. Almstead, S. Venkatraman, F.G. Njoroge, Z. Gu, V. Clausen, J.D. Graci, S.P. Jung, Y. Zheng, J.M. Colacino, F. Lahser, J. Sheedy, A. Mollin, M. Weetall, A. Nomeir, and G.M. Karp. Journal of Medicinal Chemistry, 2013. [Epub ahead of print]; PMID[24266880].
[PubMed]. OV_1122-120513.
Epstein-Barr Virus
9. Inhibition of Epstein-Barr Virus Reactivation in Nasopharyngeal Carcinoma Cells by Dietary Sulforaphane. Wu, C.C., H.Y. Chuang, C.Y. Lin, Y.J. Chen, W.H. Tsai, C.Y. Fang, S.Y. Huang, F.Y. Chuang, S.F. Lin, Y. Chang, and J.Y. Chen. Molecular Carcinogenesis, 2013. 52(12): p. 946-958; PMID[22641235].
[PubMed]. OV_1122-120513.
Herpes Simplex Virus 1
10. Tetherin Restricts Herpes Simplex Virus 1 and Is Antagonized by Glycoprotein M. Blondeau, C., A. Pelchen-Matthews, P. Mlcochova, M. Marsh, R.S. Milne, and G.J. Towers. Journal of Virology, 2013. 87(24): p. 13124-13133; PMID[24067975].
[PubMed]. OV_1122-120513.
11. SAMHD1 Restricts Herpes Simplex Virus 1 in Macrophages by Limiting DNA Replication. Kim, E.T., T.E. White, A. Brandariz-Nunez, F. Diaz-Griffero, and M.D. Weitzman. Journal of Virology, 2013. 87(23): p. 12949-12956; PMID[24067963].
[PubMed]. OV_1122-120513.
12. A Cellular Response Protein Induced During HSV-1 Infection Inhibits Viral Replication by Interacting with ATF5. Wu, L., X. Zhang, Y. Che, Y. Zhang, S. Tang, Y. Liao, R. Na, X. Xiong, L. Liu, and Q. Li. Science China. Life Sciences, 2013. 56(12): p. 1124-1133; PMID[24302293].
[PubMed]. OV_1122-120513.
Citations from the ISI Web of Knowledge Listings for O.V.
13. Identification of a Series of 1,3,4-Trisubstituted Pyrazoles as Novel Hepatitis C Virus Entry Inhibitors. Hwang, J.Y., H.Y. Kim, D.S. Park, J. Choi, S.M. Baek, K. Kim, S. Kim, S. Seong, I. Choi, H.G. Lee, M.P. Windisch, and J. Lee. Bioorganic & Medicinal Chemistry Letters, 2013. 23(23): p. 6467-6473; ISI[000326374200049].
[WOS]. OV_1122-120513.
14. Ligand Design, Synthesis and Biological anti-HCV Evaluations for Genotypes 1b and 4a of certain 4-(3-& 4- 3-(3,5-Dibromo-4-hydroxyphenyl)-propylamino phenyl) butyric acids and 3-(3,5-Dibromo-4-hydroxyphenyl)-propylamino-acetamidobenzoic acid Esters. Ismail, M.A.H., K.A.M. Abouzid, N.S. Mohamed, and E.M.E. Dokla. Journal of Enzyme Inhibition and Medicinal Chemistry, 2013. 28(6): p. 1274-1290; ISI[000326745800020].
[WOS]. OV_1122-120513.
15. Signal Transducer and Activator of Transcription 3 Is a Proviral Host Factor for Hepatitis C Virus. McCartney, E.M., K.J. Helbig, S.K. Narayana, N.S. Eyre, A.L. Aloia, and M.R. Beard. Hepatology, 2013. 58(5): p. 1558-1568; ISI[000326327600007].
[WOS]. OV_1122-120513.